Renal Business Today

Iron Management

AMAG Updates Feraheme Label

LEXINGTON, Mass.—AMAG Pharmaceuticals announced June 21 that it has updated the product label for Feraheme (ferumoxytol) Injection for Intravenous (IV) use. ...More
June 21, 2011
Posted in News, Clinical & Pharma, Government & Regulation
Rockwell Receives Patent for SFP Packaging, Method of Use

WIXOM, Mich.—The U.S. Patent and Trademark Office has issued a patent to Rockwell Medical for the packaging and method of use for its proprietary iron drug Soluble Ferric Pyrophosphate (SFP). ...More
May 11, 2011
Posted in News, Business, Government & Regulation
Rockwell Begins Second Phase III Clinical Trial for Iron Drug

WIXOM, Mich.—Rockwell Medical announced April 26 that it has initiated enrollment in its second pivotal Phase III clinical study called CRUISE-2, designed to treat iron deficiency anemia in hemodialysis dependent-chronic kidney disease patients receiving erythropoietin. ...More
April 26, 2011
Posted in News, Business, Clinical & Pharma
Sanofi-Aventis Releases New Ferrlecit Formulation

BRIDGEWATER, N.J.—In response to customer feedback, sanofi-aventis has started to sell its iron drug Ferrlecit in a new vial formulation, which is replacing the older ampule version in order to avoid and potential safety issues. ...More
April 22, 2011 By Keith Chartier
Posted in Articles, Business, Clinical & Pharma, Government & Regulation, Practice Management
Rockwell Appoints Crumbliss to Scientific Advisory Board

WIXOM, Mich.—Rockwell Medical has added Alvin L. Crumbliss, PhD, to its scientific advisory board. ...More
April 18, 2011
Posted in News, Business
FDA Approves Generic Ferrlecit

MORRISTOWN, N.J.—The U.S. Food and Drug Administration (FDA) has approved GeneraMedix Inc.’s generic version of sanofi aventis’ iron drug Ferrlecit. ...More
March 31, 2011
Posted in News, Clinical & Pharma, Government & Regulation
Rockwell Starts Phase 3 Enrollment of Iron Study

WIXOM, Mich.—Rockwell Medical has started enrollment in its phase 3 CRUISE-1 clinical study, designed to treat iron deficiency anemia in hemodialysis dependent-chronic kidney disease patients receiving erythropoietin. ...More
March 24, 2011
Posted in News, Clinical & Pharma
AMAG Increases Revenues, Narrows Losses in 2010

LEXINGTON, Mass.—AMAG Pharmaceuticals increased its revenues in 2010 while also reducing its losses, according to the company, which manufactures the iron drug Feraheme. ...More
March 1, 2011
Posted in News, Business
LDOs to Participate in Rockwell Iron Drug Studies

WIXOM, Mich.—The clinical research divisions if the two largest dialysis companies have signed agreements to participate in Rockwell Medical’s phase III studies using Soluble Ferric Pyrophosphate (SFP) as a continuous iron replacement therapeutic. ...More
January 26, 2011
Posted in News, Business, Clinical & Pharma
Rockwell's Iron Deficiency Drug Receives Patent

WIXOM, Mich.—The U.S. Patent and Trademark Office has issued a patent to Rockwell Medical for its propriety GMP (good manufacturing process) formulation for its iron drug Soluble Ferric Pyrophosphate (SFP). ...More
October 26, 2010
Posted in News, Business, Government & Regulation

featured links

HOT TOPICS

Computers & Software	Consulting, Management...
Equipment & Services	Hemodialysis Supplies
Patient Services	More Options...

Iron Management

Mobile Health Snaps

Galleries

Most Popular Articles

Buyer's Guide

Resources

Free Email Updates

featured links

First Name	Last Name
E-Mail